Scancell lauds another six months of progress The funds raised in the last year "will allow us to focus on initiating the planned Phase 2 clinical trial for our lead ImmunoBody, SCIB1, and to advance our Moditope products, Modi-1 and Modi-2, towards the clinic". [View article] Thursday 31 January 2019 13:41 Categories: Immunobody Media Coverage Modi-1 Modi-2 Moditope SCIB1 Year - 2019
Update on Cancer Research UK's Grand Challenge To download click here Wednesday 23 January 2019 13:00 Categories: Moditope News Regulatory News Year - 2019
Modi-2 : Extension of Moditope Platform To download click here To download related poster click here Tuesday 30 October 2018 12:00 Categories: Modi-2 Moditope News Regulatory News Year - 2018
Scancell Holdings part of the new cancer revolution The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology. [View article] Tuesday 25 September 2018 13:20 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 SCIB2 Year - 2018
2018 Preliminary Results To download click here Tuesday 25 September 2018 13:00 Categories: Immunobody Modi-1 Moditope News Regulatory News SCIB1 Year - 2018
Scancell Holdings extends collaboration with Sweden's Karolinska Institute The company first teamed up with Sweden's world-leading medical research university two years ago [View article] Thursday 9 August 2018 13:15 Categories: Media Coverage Moditope Year - 2018
Extension of Karolinska research collaboration To download click here Thursday 9 August 2018 13:00 Categories: Moditope News Regulatory News Year - 2018
Scancell announces grant of European patent for its Moditope® immunotherapy platform To download click here Wednesday 23 May 2018 13:00 Categories: Moditope News Regulatory News Year - 2018
Scancell receives European patent protection for immunotherapy platform The patent protects a new class of cancer vaccines rolling off the Moditope platform [View article] Wednesday 23 May 2018 10:28 Categories: Media Coverage Modi-1 Moditope Year - 2018
Scancell unveils funding plans for exciting pipeline of next-generation cancer drugs In a separate announcement, the company said it was acquiring new technology from Nottingham University that will complement its current pipeline [View article] Wednesday 18 April 2018 18:15 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 Year - 2018